Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Pediatr Diabetes. 2012 Oct 28;14(3):168–173. doi: 10.1111/pedi.12001

Table.

The pharmacodynamic and pharmacokinetic parameters (mean±SEM) with and without the InsuPatch activation after the same bolus dose of aspart insulin investigated by euglycemic clamp study.

Pharmacodynamic Parameters No InsuPatch With InsuPatch P
GIRmax (mg/kg/min) 7.2±0.7 8.0±1 0.4
T GIRmax (min) 125±8 90±6 0.002
T 50%GIRmax (min) 58±5 40±3 0.01
AUC GIR 0-300min (mg/kg) 1141±107 1280±118 0.1
AUC GIR 0-90min (mg/kg) 260±30 354±40 0.001
Pharmacokinetic Parameters* P
ΔCins (uU/mL) 32±3 45±7 0.08
ΔCmax (uU/mL) 81±8 106±11 0.04
AUC ΔCins 0-300 min (uU.min/ml) 10470±1202 13380±1670 0.02
AUC ΔCins 0-90 min (uU.min/ml) 4342±441 5846±698 0.04
*

All values calculated as increments above baseline (ΔC)

HHS Vulnerability Disclosure